Denorange Injection

About Denorange Injection

Xgeva 120mg Injection contains the active ingredient Denosumab a medication used primarily to treat osteoporosis a condition where bones become weakened and brittle It is also prescribed to prevent bone complications in patients with certain types of cancer such as multiple myeloma or bone metastases

Xgeva works by inhibiting a protein called RANK ligand which plays a key role in the breakdown of bone tissue By blocking this protein Xgeva helps increase bone density and reduces the risk of fractures particularly in postmenopausal women with osteoporosis and in cancer patients who experience bone loss due to their condition

For patients with moderate renal impairment close monitoring of kidney function may be required It is essential for individuals undergoing treatment with Xgeva to maintain adequate calcium and vitamin D levels as these nutrients are necessary for effective treatment

Xgeva should not be used in individuals who have known hypersensitivity or allergic reactions to its components It is contraindicated in children and adolescents as its safety and effectiveness in individuals under 18 years old have not been established Additionally caution is needed in patients with preexisting hypoparathyroidism low parathyroid hormone levels

As with any medication it is important for patients to discuss their medical history and current health conditions with their healthcare provider before starting Xgeva treatment